GALCANEZUMAB

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Approval Year

Substance Class	Protein Created by `admin` on `Mon Mar 31 23:37:42 GMT 2025` Edited by `admin` on `Mon Mar 31 23:37:42 GMT 2025`
Protein Type	MONOCLONAL ANTIBODY
Protein Sub Type	IGG4\|KAPPA
Sequence Origin	HUMANIZED MOUSE
Sequence Type	COMPLETE
Record UNII	55KHL3P693
Record Status	`Validated (UNII)`
Record Version

Download

Related Record	Type

Name

Type

Language

galcanezumab [INN]

Preferred Name

English

GALCANEZUMAB

Official Name

English

GALCANEZUMAB [MI]

Common Name

English

Galcanezumab [WHO-DD]

Common Name

English

HUMANISED RECOMBINANT IgG4 ANTI-CALCITONIN GENE-RELATED PEPTIDE MONOCLONAL ANTIBODY LY2951742 EX CHO

Common Name

English

LY2951742

Code

English

LY-2951742

Code

English

GALCANEZUMAB [JAN]

Common Name

English

GALCANEZUMAB [USAN]

Common Name

English

IMMUNOGLOBULIN G4, ANTI-(HUMAN CALCITONIN GENE-RELATED PEPTIDE) (HUMAN-MUS MUSCULUS CLONE III HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS CLONE III .KAPPA.-CHAIN, DIMER

Common Name

English

Classification Tree Code System Code

WHO-ATC

N02CX08

Created by admin on Mon Mar 31 23:37:42 GMT 2025 , Edited by admin on Mon Mar 31 23:37:42 GMT 2025

Code System Code Type Description

SMS_ID

100000169982

Created by admin on Mon Mar 31 23:37:42 GMT 2025 , Edited by admin on Mon Mar 31 23:37:42 GMT 2025

PRIMARY

WIKIPEDIA

Galcanezumab

Created by admin on Mon Mar 31 23:37:42 GMT 2025 , Edited by admin on Mon Mar 31 23:37:42 GMT 2025

PRIMARY

USAN

CD-46

Created by admin on Mon Mar 31 23:37:42 GMT 2025 , Edited by admin on Mon Mar 31 23:37:42 GMT 2025

PRIMARY

FDA UNII

55KHL3P693

Created by admin on Mon Mar 31 23:37:42 GMT 2025 , Edited by admin on Mon Mar 31 23:37:42 GMT 2025

PRIMARY

ChEMBL

CHEMBL3707328

Created by admin on Mon Mar 31 23:37:42 GMT 2025 , Edited by admin on Mon Mar 31 23:37:42 GMT 2025

PRIMARY

RXCUI

2058846

Created by admin on Mon Mar 31 23:37:42 GMT 2025 , Edited by admin on Mon Mar 31 23:37:42 GMT 2025

PRIMARY

MERCK INDEX

m12105

Created by admin on Mon Mar 31 23:37:42 GMT 2025 , Edited by admin on Mon Mar 31 23:37:42 GMT 2025

PRIMARY

EVMPD

SUB183792

Created by admin on Mon Mar 31 23:37:42 GMT 2025 , Edited by admin on Mon Mar 31 23:37:42 GMT 2025

PRIMARY

LACTMED

Galcanezumab

Created by admin on Mon Mar 31 23:37:42 GMT 2025 , Edited by admin on Mon Mar 31 23:37:42 GMT 2025

PRIMARY

DAILYMED

55KHL3P693

Created by admin on Mon Mar 31 23:37:42 GMT 2025 , Edited by admin on Mon Mar 31 23:37:42 GMT 2025

PRIMARY

DRUG BANK

DB14042

Created by admin on Mon Mar 31 23:37:42 GMT 2025 , Edited by admin on Mon Mar 31 23:37:42 GMT 2025

PRIMARY

NCI_THESAURUS

C166816

Created by admin on Mon Mar 31 23:37:42 GMT 2025 , Edited by admin on Mon Mar 31 23:37:42 GMT 2025

PRIMARY

DRUG CENTRAL

5316

Created by admin on Mon Mar 31 23:37:42 GMT 2025 , Edited by admin on Mon Mar 31 23:37:42 GMT 2025

PRIMARY

CAS

1578199-75-3

Created by admin on Mon Mar 31 23:37:42 GMT 2025 , Edited by admin on Mon Mar 31 23:37:42 GMT 2025

PRIMARY

RXCUI

2058868

Created by admin on Mon Mar 31 23:37:42 GMT 2025 , Edited by admin on Mon Mar 31 23:37:42 GMT 2025

ALTERNATIVE

INN

10277

Created by admin on Mon Mar 31 23:37:42 GMT 2025 , Edited by admin on Mon Mar 31 23:37:42 GMT 2025

PRIMARY

From	To
1_22	1_96
1_146	1_202
1_260	1_320
1_366	1_424
2_22	2_96
2_146	2_202
2_260	2_320
2_366	2_424
1_133	3_214
2_133	4_214
1_225	2_225
1_228	2_228
3_23	3_88
3_134	3_194
4_23	4_88
4_134	4_194

Glycosylation Link Type	Site
N	1_296
N	2_296

Related Record Type Details

GALCANEZUMAB-GNLM

SUB_CONCEPT->SUBSTANCE

Amount:


					JHB2QIZ69Z

CALCITONIN GENE-RELATED PEPTIDE

TARGET -> INHIBITOR

Interaction Type:

BINDING

Amount:

GALCANEZUMAB-GNLM

INNOVATOR->PARENT

Amount:

Related Record Type Details


					55KHL3P693

ACTIVE MOIETY

Amount:

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
MOL_WEIGHT:NUMBER(CALCULATED)	CHEMICAL
Molecular Formula	CHEMICAL